Skip to content
BidBenchmark
Special NoticeAmendment 2

6505--JERRY - Radiopharmaceuticals

241-NETWORK CONTRACT OFFICE 01 (36C241)

Response status

Historical record

Aug 18, 2026, 4:00 PM UTC

This notice is no longer open.

Posted
Aug 12, 2026
Archive date
Sep 17, 2026
SAM status
Active
This is a preserved solicitation record. The response window is closed because the published deadline passed.

Answer-first brief

What the source record says

  • 241-NETWORK CONTRACT OFFICE 01 (36C241) published this special notice.
  • The notice uses NAICS 325412 (Pharmaceutical Preparation Manufacturing).

Procurement identity

Notice ID
3b7ef94d635e42cd92f67398a54e8a57
Solicitation
36C24126Q0738
Base type
Special Notice
Version
2 of 2

Solicitation facts

Structured fields from the current SAM notice version. A dash means the source did not publish a value.

Notice type
Special Notice
Solicitation number
36C24126Q0738
Set-aside
Set-aside code
Posted
Aug 12, 2026
Responses due
Aug 18, 2026, 4:00 PM UTC
Archive date
Sep 17, 2026
Archive type
autocustom
Base type
Special Notice
Organization type
OFFICE
Benchmark category
Category confidence
Category source
Last seen
Sep 5, 2026

Buyer and place

Office hierarchy and place of performance as published.

Department
VETERANS AFFAIRS, DEPARTMENT OF
Department code
Subagency
VETERANS AFFAIRS, DEPARTMENT OF
Subagency code
Office
241-NETWORK CONTRACT OFFICE 01 (36C241)
Organization path
Organization path codes
Office address
TOGUS, ME, 04330, USA
Place of performance
City code
State
State code
Postal code
Country

Points of contact

Contact details from the current notice version.

Notice description

Source text reproduced without an AI summary.

The Department of Veterans Affairs, Networking Contracting Office (NCO 01) located in West Haven, CT, intends to enter into a sole source procurement with Novartis Pharmaceuticals Corporation for Lu-177 vipivotide tetraxetan (PLUVICTO). Authority: FAR 8.405-6(a)(1)(i) (items peculiar to one manufacturer), FAR 8.405-6(b) (limited-sources justification), MAS ordering authorities at 41 U.S.C. 152(3) and 40 U.S.C. 501, and GSAM/R 538.7104-3(b) as implemented for MAS sole-source justifications (RFO 8.4). STATEMENT OF WORK RADIOPHARMACEUTICALS Lu-177 vipivotide tetraxetan (PLUVICTO) is a radioligand therapeutic agent to perform the treatment of adult patients with prostate-specific membrane antigen (PSMA)-positive and metastatic castration-resistant prostate cancer (mCRPC) who have been treated with androgen receptor pathway inhibitor (ARPI) therapy and are considered appropriate to delay taxane-based chemotherapy or have received prior taxane-based chemotherapy. Radiopharmaceutical preparation and delivery of Lu-177 vipivotide tetraxetan (PLUVICTO) doses performed at contractor facility provided by a board-certified radiopharmacist and delivered to the Nuclear Medicine Service at VA Connecticut Healthcare located at 950 Campbell Ave., West Haven, CT, building one, ground floor. Deliveries will be made Monday through Friday between 7:00 am and 3:00 pm.� Personnel assigned by the contractor to perform services covered by this contract shall be licensed in a State, Territory, or Commonwealth of the United States or the District of Columbia. A total of 74 doses of Pluvicto to treat prostate-specific membrane antigen (PSMA)-Positive. Contractor s employees will deliver to the PET/CT Service and give deliveries directly to the PET Technologist on duty. Delivery personnel will be bonded by the contractor. The contractor will provide for the placement of one or more telephone delivery order (s) per day for items listed in the Pricing and Cost Schedule, 24 hours per day, seven days a week, including holidays. Contractor must be licensed by the Nuclear Regulatory Commission and be regularly established in the business of providing radiopharmaceuticals. The offeror must provide copies of licenses and certifications along with a quote to the Contracting Officer. DELIVERY ORDERS: Due to the demands of the Medical Center care requirements, there shall be no restriction to the number of orders which may be placed by VA, nor the number of deliveries required per day. In the event that the requirements may be determined in advance, a longer delivery time will be scheduled accordingly. The delivery order shall specify contract item (s) and quantity, time (s) of delivery and applicable VA order number. Orders can be placed orally by telephone and/or online. DELIVERY LOCATION: VA Connecticut Healthcare System. 950 Campbell Ave. West Haven, CT 06516. PET Center and/or Mobile PET Unit; building one. Deliveries will be made Monday-Friday (excluding holidays which are listed below) between the hours of 7:00 AM and 3:00 PM. Federal Holidays are as follows and include any other days specifically declared by the President of the United States to be deemed a holiday. New Year s Day Juneteenth Thanksgiving Martin Luther King s Birthday Independence Day Veterans Day Presidents Day Columbus Day Christmas Memorial Day Labor Day Access to the VAMC location during non-business hours shall be obtained by contacting the AOD located in the Emergency Department who will contact VA Police to accompany the delivery Person to the PET Center and supervise the delivery. Deliveries will be supervised by the COR or their designee before beginning delivery operations. The contractor will contact the COR prior to delivery to arrange for delivery supervision. DELIVERY COMMITMENT: Time of delivery specified or mutually agreed to at the time of receipt of telephone order shall become mandatory upon the Contractor. Failure to perform in accordance with the delivery commitment may be grounds for termination of contract in accordance with the provisions for default. PERIOD OF PERFORMANCE: The contract will have a Period of Performance from 9/1/2026 to 8/31/2027. SUPPLIES OR SERVICES AND PRICES/COSTS: Contractor to provide Radiopharmaceutical product, PLUVICTO, as requested by authorized VA Staff, to support the West Haven campus of VA Connecticut Healthcare System (VACHS), 950 Campbell Ave, West Haven, CT 06516. PERSON AUTHORIZED TO PLACE ORDERS: In addition to the Contracting Officer, the COR is authorized to place orders under this contract, as well as any Certified Nuclear Medicine Technologist employed by the West Haven VA Hospital. NOTIFICATION: The services specified herein may be changed by written modification. The modification will be prepared by the VA Contracting Officer. The NAICS code for this requirement is 325412. Novartis Pharmaceuticals Corporation is the only contractor capable of providing PLUVICTO. Novartis Pharmaceuticals Corporation is the sole Food & Drug Administration (FDA) approved source of this highly specialized therapeutic radiopharmaceutical, PLUVICTO (Lutetium Lu-177 Vipivotide Tetraxetan) This notice of intent is not a solicitation nor is it a request for proposal. However, interested parties that believe they can satisfy the requirement must clearly identify their capability to do so in writing by Tuesday, August 18, 2026, at 12 pm EST time. Response should be sent to Jerry Choinski at Jerry.Choinski@va.gov. Information submitted in response to this notice will be used solely to determine whether competitive procedures could be used for this acquisition. A determination not to open this requirement to competition based upon responses to this notice is solely within the discretion of the Government. Disclaimer: A solicitation will not be issued. The Government reserves the right to verify all documentation and is not obligated to award based on responses. A Limited-Sources Justification supporting this sole-source action will be posted after award in accordance with FAR 8.405-6 and FAR 5.301.

Comparable award range

Historical award values for work matched by the fixed rubric—not an estimate of this opportunity.

Low end (p25)$7,080
Median$22,639
High end (p75)$74,017
Comparable awards
50
Median
$22,639
Computed
Aug 15, 2026
Rubric
comparables@2026.08.1
Comparable award values describe completed contracts. They do not state the government's budget and are not a bid recommendation.

Comparable awards

The match score is decomposed so each comparison can be challenged.

AwardContractorValueAwardedScoreWhy it matched
PURCHASE OF BOOSTRIX PFS 0.5ML, TYPHIM VI, RABAVERT 1ML, HAVRIX TPL, HEPLISAV-B 20MCG 0.5MMCKESSON CORPORATION$25,863.68May 11, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
INV 7633644043 PR-504-000820 GUYANA CANCELLED FOR MCKESSONMCKESSON CORPORATION$19,605.60May 11, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
INV 7637193599 PR-515-000536 COSTA RICA CANCELLED FOR MCKESSONMCKESSON CORPORATION$20,501.16May 27, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
VOLUNTEER MEDICAL SUPPLIESMCKESSON CORPORATION$26,485.05Jul 14, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MEDICAL ORDER 517-26-008MCKESSON CORPORATION$34,583.11Jul 15, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MCKESSON REGULAR AND CONTROL MEDICATIONS FOR FCI DANBURY JUNE-SEPTEMBERMCKESSON CORPORATION$393,480.34Jul 14, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MCKESSON MAT MEDICATIONS FOR FCI DANBURY JUNE-SEPTEMBER EO 14398MCKESSON CORPORATION$52,719.00Jul 29, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
CONTRACT MEDICATIONS FOR JULY FY26- FCI LORETTOMCKESSON CORPORATION$90,000.00Jun 12, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
Q4 FY26 MCKESSON NARCOTIC CONTRACT MEDICATIONS FOR FCI LORETTOMCKESSON CORPORATION$300.00Jun 12, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
CONTRACT MEDICATIONS FCI LORETTOMCKESSON CORPORATION$202,293.29Jul 28, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FPC DULUTH FY26 MCKESSON CONTROLLED MEDICATION ORDER FOR Q3 FY26. ORDER ISSUED IN ACCORDMCKESSON CORPORATION$400.00Jul 8, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MEDICATIONSMCKESSON CORPORATION$9,781.02Jun 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MCKESSON MAT MEDICATION JUN 26MCKESSON CORPORATION$9,876.72Jun 10, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON MEDICATION JUN 26MCKESSON CORPORATION$3,334.35Jun 10, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON MEDICATION JUL 26MCKESSON CORPORATION$745.43Jul 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 FSA MCKESSON MAT MEDICATION JUL 26MCKESSON CORPORATION$9,310.25Jul 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON CONTROLLED MEDICATIONS JUL 26MCKESSON CORPORATION$29.70Jul 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
MEDICATIONSMCKESSON CORPORATION$93,443.16Jun 10, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON OPEN MARKET MEDS QTR4MCKESSON CORPORATION$10,000.00Jun 16, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)
FY26 B1 MCKESSON NON-CONT/CONT. JULY 2026MCKESSON CORPORATION$65,000.00Jul 9, 202652Same product and service code (25), Same industry code (20), Recent enough to be relevant (7)

Amendment history

A version is preserved whenever the normalized notice contents change.

VersionNotice typeObservedResponses dueContent hash
1Special NoticeAug 14, 2026Aug 18, 2026, 4:00 PM UTC1bad2e6e969d6c11
2Special NoticeAug 28, 2026Aug 18, 2026, 4:00 PM UTC563d15dbd5fe7d3d

Record provenance

Field-level lineage for the current opportunity version.

FieldSourceSource as ofParserTransform
agency_nameSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_dateSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
archive_typeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
base_typeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
contactsSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
descriptionSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
naics_codeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_idSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
notice_typeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_citySAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_country_codeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_nameSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_postal_codeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
office_state_codeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
organization_typeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
posted_dateSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
psc_codeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
response_deadlineSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
sam_urlSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
solicitation_numberSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
subagency_nameSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
titleSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3
upstream_activeSAM.gov Contract OpportunitiesAug 14, 2026sam_opportunity_snapshot@2026.08.22026.08.3

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

Comparable awards are scored on benchmark category, product and service code, industry code, buyer, place, recency, and contract type. Rubric version comparables@2026.08.1.

  1. 1Notice fields come from the SAM.gov contract opportunities record last seen Sep 5, 2026. SAM.gov remains authoritative.
  2. 2Computed from 50 completed federal awards using comparables@2026.08.1, as of Aug 15, 2026. Award values are neither unit prices nor a forecast.

Note 1 covers the solicitation record; note 2 covers the comparable range. No synthetic FAQ or inferred solicitation value is published.

6505--JERRY - Radiopharmaceuticals — federal contract opportunity · BidBenchmark